Back
Keros Therapeutics 10K Form
Sell
14
KROS
Keros Therapeutics
Last Price:
$13.48
Seasonality Move:
8.33%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive KROS News And Ratings
See the #1 stock for the next 7 days that we like better than KROS
KROS Financial Statistics
Sales & Book Value
| Annual Sales: | $3.6M |
|---|---|
| Cash Flow: | $160.6M |
| Price / Cash Flow: | 12.07 |
| Annual Sales: | $17.97 |
| Price / Book: | 0.75 |
Profitability
| EPS (TTM): | -0.18000 |
|---|---|
| Net Income (TTM): | $4.2M |
| Gross Margin: | -- |
| Return on Equity: | 0.78% |
| Return on Assets: | 0.72% |
Keros Therapeutics Earnings Forecast
Key Keros Therapeutics Financial Ratios
-
The Research & Development expenses have been 4,890.96% of Revenue.
-
The Net Earning history of KROS is -5,277.55% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 2 years.
Keros Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | KROS |
| CUSIP: | 492327 |
| Website: | kerostx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 19.29 |
| Quick Ratio: | 18.79 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
KROS Technical Analysis vs Fundamental Analysis
Sell
14
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy or a Sell?
-
Keros Therapeutics stock is rated a SellThe current Keros Therapeutics [KROS] share price is $13.49. The Score for KROS is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.